Isabelle Desombere
- Hepatology top 0.5%
- Hepatitis C virus research 26
- Epidemiology top 2%
- Hepatitis B Virus Studies 35
- Liver Disease Diagnosis and Treatment 9
- Virology top 5%
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 24
- COVID-19 Clinical Research Studies 14
- SARS-CoV-2 detection and testing 7
- Immunology top 5%
- Immunotherapy and Immune Responses 16
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- Geert Leroux‐RoelsPhilip MeulemanThomas VanwolleghemAssad SafaryS ThoelenJane A. McKeatingZania StamatakiAli Farhoudi
- Cited by
- HepatologyEpidemiologyVirology
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Isabelle Desombere
72 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 93
- Hepatology 1.4k
- Epidemiology 1.6k
- Virology 178
- Infectious Diseases 514
- Immunology 569
Countries citing papers authored by Isabelle Desombere
This map shows the geographic impact of Isabelle Desombere's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Desombere with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Desombere more than expected).
Fields of papers citing papers by Isabelle Desombere
This network shows the impact of papers produced by Isabelle Desombere. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Desombere. The network helps show where Isabelle Desombere may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Isabelle Desombere, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 2 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 19 | |
| 9 | 2021 | 7 | |
| 10 | 2017 | 20 | |
| 11 | 2017 | 8 | |
| 12 | 2010 | 1 | |
| 13 | 2008 | 117 | |
| 14 | 2005 | 37 | |
| 15 | A candidate therapeutic vaccine for chronic hepatitis C infection based on envelope 1 protein: Tolerability and immunogenicity in healthy adult volunteers | 2001 | 5 |
| 16 | 2001 | 16 | |
| 17 | A hepatitis B vaccine with a novel adjuvant: immunogenicity and reactogenicity profile in adult vaccine nonresponders | 1999 | 3 |
| 18 | 1997 | 36 | |
| 19 | 1996 | 36 | |
| 20 | Immunogenicity of a new hepatitis B vaccine containing preS1 and preS2 epitopes | 1993 | 1 |
About Isabelle Desombere
Isabelle Desombere is a scholar working on Hepatology, Infectious Diseases and Epidemiology, having authored 72 papers that have together received 2.4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (35 papers), Hepatitis C virus research (26 papers), SARS-CoV-2 and COVID-19 Research (24 papers), Immunotherapy and Immune Responses (16 papers), COVID-19 Clinical Research Studies (14 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and SARS-CoV-2 detection and testing (7 papers). The work is most often cited by research in Hepatology (1.4k citations), Epidemiology (1.6k citations) and Virology (178 citations). Isabelle Desombere has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Geert Leroux‐Roels, Philip Meuleman, Thomas Vanwolleghem, Assad Safary, S Thoelen, Jane A. McKeating, Zania Stamataki, Ali Farhoudi, Pierre Van Damme and Jennifer M. Timpe. Their work appears in journals such as The Journal of Immunology, Hepatology and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.